Clinical Trials Logo
  1. Home
  2. T2DM (Type 2 Diabetes Mellitus)
  3. NCT05279911

Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion

T2DM (Type 2 Diabetes Mellitus) Clinical Trial

Official title:
Influence of Low-level Laser Therapy on Radiographic and Biochemical Profiles in Type II Controlled Diabetic Patients After Dental Implant Insertion: A Randomized Case Control Study

Clinical Trial Summary

This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. 40 T2DM patients were included in this study. Implants were randomly inserted in 20 non-lased T2DM patients (Control) and 20 lased T2DM patients (Intervention). BD and OPG levels in the PICF were assessed in both groups at the follow up points.

Clinical Trial Description

Background and objectives: Use of low-level laser therapy (LLLT) with dental implants has been suggested to improve bone quality during osseointegration. However, there is a lack of evidence about its influence on dental implants in diabetic patients. Osteoprotegrin (OPG) levels was reported as a biomarker for bone turnover to distinguish implant prognosis. This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. Methods: 40 T2DM patients were included in this study. Implants were randomly inserted in 20 non-lased T2DM patients (Control) and 20 lased T2DM patients (Intervention). BD and OPG levels in the PICF were assessed in both groups at the follow up points. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05279911
Study type Interventional
Source Sinai University
Contact
Status Completed
Phase N/A
Start date March 3, 2021
Completion date January 22, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT01373814 - Nutritional Therapy for Diabetic Cardiomyopathy
Recruiting NCT05469659 - Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Phase 2
Completed NCT05376930 - Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. Phase 3
Recruiting NCT04682795 - Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM N/A
Recruiting NCT06350890 - Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Phase 3
Completed NCT04634500 - The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. Phase 3
Recruiting NCT03789695 - RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD Phase 4
Completed NCT04632862 - The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. Phase 3
Completed NCT04688359 - Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM N/A
Completed NCT05983289 - Single Escalating Dose Study Of HSK7653 In Healthy Subjects Phase 1
Recruiting NCT04272359 - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Not yet recruiting NCT06094491 - Virtual Diabetes Group Visits Across Health Systems N/A
Completed NCT03467932 - A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus Phase 2
Completed NCT05376969 - Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin Phase 3
Active, not recruiting NCT03257449 - Effect of Viscous Soluble Fibres on Body Weight N/A
Terminated NCT04754334 - A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Phase 3
Not yet recruiting NCT06293417 - To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Not yet recruiting NCT03658031 - Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Phase 3
Terminated NCT03067480 - Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients N/A
Completed NCT03155087 - PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy N/A